Unanticipated transient sciatic nerve deficits from intra-wound liposomal bupivacaine injection during total hip arthroplasty

• Main Authors: Wesley H. Bronson, MD, MSB, James P. Doran, BS, James Slover, MD, Donato Perretta, MD, Richard Iorio, MD
• Format: Article
• Language: English
• Published: Elsevier 2015-06-01
• Series: Arthroplasty Today
• Subjects: Arthroplasty; Liposomal bupivacaine; Exparel; Postsurgical analgesia; Postoperative neurologic deficits
• Online Access: http://www.sciencedirect.com/science/article/pii/S2352344115000308

Liposomal bupivacaine (Exparel®) is a novel formulation of local anesthetic used to provide extended postoperative analgesia as part of a multimodal pain control regimen in patients undergoing total joint arthroplasty. In the three total hip arthroplasty cases described, all patients exhibited a transient loss of neurologic function in the sciatic nerve distribution of the operated extremity lasting between 24 and 72 h during the immediate postoperative period. Due to the nature and duration of the deficits, it was concluded that they likely occurred as a result of unintended injection of the medication in close proximity to the sciatic nerve. To the best of our knowledge, these events have yet to be reported in the current literature. We recommend orthopaedic surgeons pay special attention during infiltration of the medication at the surgical site to avoid postoperative neurological deficits.